Evidence map›Paper›PMID 29961577›Full record

ArticleCell2018

A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins.

Jie Wang, Jeong-Mo Choi, Alex S Holehouse, Hyun O Lee, Xiaojie Zhang, Marcus Jahnel, Shovamayee Maharana, Régis Lemaitre, Andrei Pozniakovsky, David Drechsel and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,165 papers.

0numbers the graph read from it
0cells of the map it votes in
1,165citing papers in PubMed
71.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,165 citing papers in PubMed, 2,160 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

1,105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Jie WangMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Jeong-Mo ChoiDepartment of Biomedical Engineering and Center for Biological Systems Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA.
Alex S HolehouseDepartment of Biomedical Engineering and Center for Biological Systems Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA.
Hyun O LeeMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Xiaojie ZhangMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Marcus JahnelMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Shovamayee MaharanaMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Régis LemaitreMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Andrei PozniakovskyMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
David DrechselResearch Institute of Molecular Pathology, Campus-Vienna-Biocenter 1, 1030 Vienna, Austria.
Ina PoserMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Rohit V PappuDepartment of Biomedical Engineering and Center for Biological Systems Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA.
Simon AlbertiMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany. Electronic address: alberti@mpi-cbg.de.
Anthony A HymanMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany. Electronic address: hyman@mpi-cbg.de.
Max Planck Institute of Molecular Cell Biology and Genetics · DEWashington University in St. Louis · USResearch Institute of Molecular Pathology · AT

Funding

ROLE OF CHAIN LENGTH AND SEQUENCE CONTEXTS ON POLYGLUTAMINE OLIGOMERIZATIONR01NS056114 · NINDS · WASHINGTON UNIVERSITY · PI PAPPU, ROHIT V · 2007 to 2020
$4.4M
NINDS NIH HHS R01 NS056114
6 · The paper itself

Abstract

Proteins such as FUS phase separate to form liquid-like condensates that can harden into less dynamic structures. However, how these properties emerge from the collective interactions of many amino acids remains largely unknown. Here, we use extensive mutagenesis to identify a sequence-encoded molecular grammar underlying the driving forces of phase separation of proteins in the FUS family and test aspects of this grammar in cells. Phase separation is primarily governed by multivalent interactions among tyrosine residues from prion-like domains and arginine residues from RNA-binding domains, which are modulated by negatively charged residues. Glycine residues enhance the fluidity, whereas glutamine and serine residues promote hardening. We develop a model to show that the measured saturation concentrations of phase separation are inversely proportional to the product of the numbers of arginine and tyrosine residues. These results suggest it is possible to predict phase-separation properties based on amino acid sequences.

Indexed as

Amino AcidsAmino Acid SequenceAnimalsArginineComputer SimulationHeLa CellsHumansIntrinsically Disordered ProteinsPhase TransitionPrion ProteinsPrionsProtein DomainsRNA-Binding Protein FUSRNA-Binding ProteinsSf9 CellsTyrosineAmino AcidsArginineIntrinsically Disordered ProteinsPrion ProteinsPrionsRNA-Binding Protein FUSRNA-Binding ProteinsTyrosinecation-πFUSintrinsically disorderedlow complexitymembraneless compartmentsphase separationPLDprion-likeprion-like RNA binding proteinssaturation concentration

Identifiers

PMID29961577
PMCPMC6063760
OpenAlexW2810866092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.